What is the workup for a patient with suspected increased mineralocorticoid (mineralocorticoid) precursors and an abnormal overnight 1 milligram (mg) dexamethasone (dexamethasone) suppression test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Suspected Increased Mineralocorticoid Precursors with Elevated Overnight 1 mg Dexamethasone Suppression Test

In a patient with suspected increased mineralocorticoid precursors (congenital adrenal hyperplasia) and an abnormal overnight 1 mg dexamethasone suppression test, you should immediately confirm autonomous cortisol secretion with 24-hour urinary free cortisol (preferably multiple collections) and/or midnight salivary cortisol, then measure plasma ACTH to differentiate ACTH-dependent from ACTH-independent causes, followed by measurement of specific steroid precursors including deoxycorticosterone (DOC), 11-deoxycortisol, and androgens to confirm the specific enzyme deficiency. 1

Initial Confirmation of Hypercortisolism

The elevated overnight 1 mg dexamethasone suppression test requires confirmation before proceeding with extensive workup, as this test has significant limitations in mild or episodic hypercortisolism:

  • Repeat screening tests are essential: Perform at least 2-3 additional screening tests including 24-hour urinary free cortisol (preferably multiple collections) and midnight salivary cortisol to confirm true hypercortisolism 2, 3
  • Interpret the dexamethasone suppression test carefully: A serum cortisol >1.8 μg/dL (50 nmol/L) at 8 AM suggests autonomous cortisol secretion, though cortisol >5.0 μg/dL (138 nmol/L) provides stronger evidence 2
  • Be aware of false positives: The 1 mg overnight dexamethasone test has poor sensitivity (18-41%) in patients with mild or episodic Cushing's syndrome, meaning many patients with true disease will suppress inappropriately 4, 5

Critical Pitfall: Rule Out Confounding Factors

Before interpreting any abnormal dexamethasone suppression test, you must exclude factors that cause false results:

  • CYP3A4 inducers (phenobarbital, carbamazepine, St. John's wort) accelerate dexamethasone metabolism, causing falsely elevated cortisol levels 2, 6
  • CYP3A4 inhibitors (fluoxetine, cimetidine, diltiazem) slow dexamethasone metabolism, potentially causing false-negative results 2, 6
  • Oral estrogens increase corticosteroid-binding globulin, elevating total cortisol measurements 6
  • Malabsorption conditions (celiac disease, chronic diarrhea) affect dexamethasone absorption 6
  • Consider measuring dexamethasone levels concomitantly with cortisol (threshold ≥4.5 nmol/L indicates adequate absorption) to identify false positives from inadequate drug levels 2, 6

Measure Plasma ACTH: The Pivotal Differentiating Test

Once hypercortisolism is confirmed, plasma ACTH determines the diagnostic pathway:

  • Morning plasma ACTH measurement (ideally 8 AM) differentiates ACTH-dependent from ACTH-independent causes 3
  • ACTH >5 ng/L indicates ACTH-dependent disease, which includes Cushing's disease, ectopic ACTH syndrome, and congenital adrenal hyperplasia 3
  • ACTH <5 ng/L suggests ACTH-independent disease, pointing toward primary adrenal pathology like adenoma or carcinoma 3
  • In congenital adrenal hyperplasia, ACTH is typically elevated due to impaired cortisol synthesis and loss of negative feedback 1

Specific Testing for Congenital Adrenal Hyperplasia

When congenital adrenal hyperplasia is suspected (early-onset hypertension, resistant hypertension, hypokalemia, virilization signs, or incomplete masculinization), proceed with:

Biochemical Confirmation

  • Measure aldosterone and renin levels: Both should be low or normal in mineralocorticoid excess syndromes from CAH, distinguishing this from primary aldosteronism 1
  • Check serum electrolytes: Hypokalemia is common with 11-beta-hydroxylase deficiency; hyperkalemia may occur with other enzyme defects 1

Steroid Precursor Measurement

  • For 11-beta-hydroxylase deficiency: Measure elevated deoxycorticosterone (DOC), 11-deoxycortisol, and androgens 1
  • For 17-alpha-hydroxylase deficiency: Measure decreased androgens and estrogen, with elevated deoxycorticosterone and corticosterone 1
  • Urinary cortisol metabolites provide additional diagnostic information 1
  • Genetic testing confirms the specific enzyme deficiency and guides family counseling 1

Concurrent Evaluation for Primary Aldosteronism

Given the clinical overlap between CAH and primary aldosteronism in patients with hypertension and hypokalemia:

  • Measure aldosterone-to-renin ratio in the morning after 2 hours upright and 5-15 minutes seated if hypertension or hypokalemia is present 3
  • A ratio >20 ng/dL per ng/mL/hr has >90% sensitivity and specificity for hyperaldosteronism 3
  • In CAH, both aldosterone and renin should be low or normal, distinguishing it from primary aldosteronism where aldosterone is elevated 1

Adrenal Imaging

After biochemical confirmation:

  • Adrenal CT scan (non-contrast initially) characterizes adrenal morphology 3
  • <10 Hounsfield units suggests benign adenoma; higher values or bilateral hyperplasia support CAH diagnosis 3
  • Look for bilateral adrenal hyperplasia, which is characteristic of ACTH-dependent conditions including CAH 1

Clinical Examination Clues

Physical examination findings guide the specific enzyme deficiency suspected:

  • 11-beta-hydroxylase deficiency: Signs of virilization (hirsutism, acne, clitoromegaly in females, precocious puberty in males) 1
  • 17-alpha-hydroxylase deficiency: Incomplete masculinization in males, primary amenorrhea in females, absence of secondary sexual characteristics 1
  • Check blood pressure in all extremities: Elevated BP with hypokalemia is the hallmark presentation 1

Important Caveat About Dexamethasone Testing in CAH

The overnight 1 mg dexamethasone suppression test is designed to screen for Cushing's syndrome, not CAH. In CAH patients:

  • Cortisol levels may be normal or low despite elevated ACTH, as the enzyme deficiency impairs cortisol synthesis 1
  • An "abnormal" dexamethasone test in CAH may reflect the underlying cortisol deficiency rather than autonomous cortisol excess 1
  • The test may be misleading if interpreted solely for Cushing's syndrome without considering the broader differential 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dexamethasone Suppression Test Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach to Elevated 24-Hour Urinary Free Cortisol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2006

Research

Low-Dose and Standard Overnight and Low Dose-Two Day Dexamethasone Suppression Tests in Patients with Mild and/or Episodic Hypercortisolism.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2018

Guideline

Dexamethasone Suppression Test Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.